what was the first glp 1 agonist Historical timeline of GLP-1 biology, receptor agonist discovery, what was the first glp

Learn more about its role in diabetes management.

Learn how employers can manage GLP-1 costs with strategies that balance affordability and access.

Subtle support that works with your habits, not against them

By Sabina Paglialunga, PhD & Aernout van Haarst, PhD Senior Directors Scientific Affairs Glucagon-Like Peptide-1 (GLP-1) receptor agonists first came to the market in 2005 as a type 2 diabetes mellitus treatment, and they have been making headlines again for their weight reduction effects

Learn what the ads don't tell you, and how lifestyle medicine offers a more lasting path.

Purpose of Review This review will summarize the most contemporary trials for glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2-i) and present guidance on management and recommendations on adjunctive tapering of insulin in patients with insulin-dependent diabetes mellitus, which we term de-insulinization. Recent Findings GLP1-RA and SGLT2-i are the principal classes of diabetes medications evidencing cardiovascular benefit